Under construction – not a live service
Sign in
Not yet taking people in SwedenNo phase

Tests bicycle exercise in people with persistent atrial fibrillation

Tests whether bicycle exercise helps adults with persistent atrial fibrillation before electrical cardioversion.

Plain-language title generated from the registry record
Registry title: Exercise-induced Cardioversion in Persistent Atrial Fibrillation

Key facts

Where
Västerås, SwedenSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT07008066, who can take part

Where in Sweden

  • Centre for Clinical Research, Uppsala University, Västmanland County HospitalVästerås, SwedenNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Uppsala University
Trial code
NCT07008066
Record updated
6 June 2025
Original description
This study aims to to evaluate the feasibility of conducting a larger randomized controlled trial (RCT) to assess whether an exercise stress test on an ergometer bicycle could induce sinus rhythm in patients with persistent AF scheduled for electrical cardioversion and if this intervention (regardless of rhythm conversion) could improve health-related quality of life in these patients.Read full original descriptionShow less

Exercise-induced Cardioversion in Persistent Atrial Fibrillation (ExPAF): A Feasibility Pilot Study

This study aims to to evaluate the feasibility of conducting a larger randomized controlled trial (RCT) to assess whether an exercise stress test on an ergometer bicycle could induce sinus rhythm in patients with persistent AF scheduled for electrical cardioversion and if this intervention (regardless of rhythm conversion) could improve health-related quality of life in these patients.

Inclusion: Adults (18-75 years) with persistent AF; planned for EC; with at least 3 weeks of therapeutic oral anticoagulation before intervention.

Exclusion: Ischemic heart disease; Heart failure; Severe valvular disease; Unable to perform a symptom limited cycle exercise test; Unable to speak and write Swedish language; Unable to provide written, informed consent.

ClinicalTrials.gov NCT07008066